PROFILE |
 |
The Wellcome Trust is one of the world's largest medical research charities. It funds mainly biomedical research, history of medicine research, and genome sequencing, endowing British universities, projects in developing countries, and the Human Genome Project. The trust uses income from investments for the nearly £600 million it grants each year. Catalyst BioMedica, Wellcome's business subsidiary, funds commercially viable research that isn't attractive to other investors. In accordance with the will of Sir Henry Wellcome, the Wellcome Trust was established in 1936 from shares of The Wellcome Foundation (which became Glaxo Wellcome and is now GlaxoSmithKline); the trust and the corporation are independent.
COMPETITION |
 |
Celera Genomics Group (CRA)
Howard Hughes Medical Institute (dossier)
SRI International (dossier)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: September
2000 Sales (mil.): 454.40
1-Yr. Sales Growth: (10.1)%
Employees: 1,058
Revenue per employee: $429,489.60
KEY PEOPLE |
 |
Sir Dominic Cadbury
CEO
CONTACT INFO |
 |
The Wellcome Bldg.,
London NW1 2BE, United Kingdom
Phone: 44-20-7611-8888
Fax: 44-20-7611-8545
Online: Web Site
|